Click Chemistry

DBCO-PEG3-GGFG-Exatecan is a drug-linker conjugate designed for use in antibody-drug conjugate (ADC) applications. This compound features the DBCO-PEG3-GGFG linker combined with Exatecan, a potent DNA topoisomerase I inhibitor. It is engineered to enhance the targeted delivery of cytotoxic agents to cancer cells, thereby improving therapeutic efficacy. DBCO-PEG3-GGFG-Exatecan is suited for research in cancer biology and the development of novel treatment strategies.

DBCO-PEG4-Ahx-DM1 is a drug-linker conjugate that incorporates the potent microtubulin inhibitor DM1, designed to facilitate antibody-drug conjugate (ADC) development. DM1, a maytansinoid, targets microtubules to inhibit cancer cell proliferation while minimizing systemic toxicity. The DBCO moiety in this compound allows for strain-promoted alkyne-azide cycloaddition (SPAAC) with azide-containing biomolecules, enabling efficient conjugation for targeted delivery in cancer research applications.

DBCO-PEG3-Glu-VC-PABC-MMAF is a drug-linker conjugate designed for use in antibody-drug conjugates (ADCs). It features the tubulin inhibitor MMAF linked through a cathepsin cleavable DBCO-PEG3-Glu-VC-PABC moiety, facilitating targeted delivery of the cytotoxic agent. This compound is valuable for research applications focusing on the development of ADCs, enabling studies on efficacy, mechanism of action, and therapeutic potential in cancer treatment.

Mivebresib-alkyne functions as a Click Reaction Agent, facilitating the synthesis of BRD4-targeted PROTACs. This derivative of Mivebresib serves as an important tool for researchers investigating targeted protein degradation pathways and their potential therapeutic applications. Its unique alkyne functionality enables efficient conjugation reactions, enhancing the versatility of PROTAC development in chemical biology studies.

Cyanine5 DBCO hexafluorophosphate is an azide-reactive probe designed for copper-free "click" reactions, enabling the selective imaging of azide-labeled biomolecules. This near-infrared fluorescent dye exhibits low toxicity to cells, making it suitable for both in vitro and in vivo applications without compromising the physiological functions of non-target cells. Its optimal excitation and emission wavelengths (Ex=635 nm, Em=650-700 nm) facilitate efficient cellular labeling and tracking, providing valuable insights in biological research.

DBCO-PEG3-TCO is a non-cleavable linker designed for the synthesis of antibody-drug conjugates (ADCs), featuring a 3-unit polyethylene glycol (PEG) spacer. This reagent facilitates click chemistry through its dibenzocyclooctyne (DBCO) moiety, enabling strain-promoted alkyne-azide cycloaddition (SPAAC) with azide-functionalized compounds. Additionally, the TCO group supports inverse electron demand Diels-Alder (iEDDA) reactions with tetrazine-containing molecules, making DBCO-PEG3-TCO a versatile tool for advancing ADC development in therapeutic research.

Alkyne-SNAP is an alkyne-conjugated benzylguanine that serves as a reactive probe for SNAP-tag fusion proteins. The benzylguanine component enables irreversible and covalent labeling, facilitating the study of protein dynamics and interactions. This reagent is particularly valuable for applications involving click chemistry, allowing the introduction of further functional groups for bioconjugation and subsequent analyses in various biological research contexts.

DBCO-NHCO-PEG4-NH-Boc is a versatile PROTAC linker featuring a cleavable structure designed for the synthesis of PROTACs and antibody-drug conjugates (ADCs). This compound utilizes a DBCO moiety, enabling efficient strain-promoted alkyne-azide cycloaddition (SPAAC) with azide-containing molecules. Its PEG4 spacer enhances solubility and stability, making it suitable for various biological applications in drug development and therapeutic research.

DBCO-NHCO-PEG4-amine is a PEG-based linker designed for use in antibody-drug conjugates (ADCs) and PROTACs. This cleavable linker facilitates the conjugation of payloads such as MMAE to antibodies, enhancing targeted delivery to cancer cells. It has demonstrated compelling biological activities, with EC50 values of 280 nM and 22 nM for DBCO-VCpAB MMAE and DBCO-TRX MMAE, respectively, in SKBR3 cells, making it a valuable tool for researchers investigating targeted therapies.

BCN-exo-PEG3-maleimide is an ADC linker featuring three PEG units and a bidentate macrocyclic ligand, BCN. It facilitates the formation of stable triazole structures through click chemistry with azide-containing molecules, eliminating the need for catalysts. The maleimide moiety is designed to degrade in aqueous conditions, making it suitable for various drug delivery applications and enhancing the efficacy of antibody-drug conjugates (ADCs) in targeted therapy research.

DBCO-N-bis(PEG4-NHS ester) is a bifunctional polyethylene glycol (PEG) linker featuring two NHS ester groups and a dibenzocyclooctyne (DBCO) moiety. This reagent facilitates protein modification and labeling, enhancing bioconjugation applications. As a click chemistry tool, DBCO-N-bis(PEG4-NHS ester) enables efficient strain-promoted alkyne-azide cycloaddition (SPAAC) with azide-containing molecules, making it valuable for constructing PROTAC molecules and other bioorthogonal conjugates in various biochemical research settings.

bis-PEG2-endo-BCN is a cleavable linker designed for the synthesis of antibody-drug conjugates (ADCs). This compound features a cyclooctyne (BCN) moiety that facilitates strain-promoted alkyne-azide cycloaddition (SPAAC) with azide-containing molecules, enabling precise conjugation. Its implementation in ADC development enhances targeted delivery of therapeutics, making it valuable for research applications in oncology and drug development.

DBCO-PEG24-acid is a click chemistry reagent that incorporates a dibenzocyclooctyne (DBCO) group linked to a hydrophilic polyethylene glycol (PEG) chain. This compound facilitates copper-free click reactions, leveraging the high energy associated with the DBCO moiety for efficient bioconjugation. The terminal carboxylic acid allows for the formation of stable amide bonds with primary amines in the presence of coupling agents such as EDC or HATU. It is a valuable tool in bioconjugation studies and the development of drug delivery systems.

DBCO-NHS Ester 3 is a cleavable linker designed for the synthesis of antibody-drug conjugates (ADCs). This compound features a dibenzocyclooctyne (DBCO) moiety that facilitates strain-promoted alkyne-azide cycloaddition (SPAAC) with azide-containing molecules, enabling efficient conjugation. DBCO-NHS Ester 3 is utilized in various applications involving targeted drug delivery and bioconjugation strategies in chemical biology and therapeutic development.

Gly-Gly-Gly-PEG4-methyltetrazine is a cleavable polyethylene glycol (PEG) linker designed for use in antibody-drug conjugates (ADCs). It features a tetrazine moiety that facilitates rapid and selective conjugation through an inverse electron demand Diels-Alder (iEDDA) reaction with trans-cyclooctene (TCO) derivatives. This compound enhances the stability and efficacy of ADCs, making it valuable for targeted delivery of therapeutics in cancer research and other applications in bioconjugation.

DBCO-C3-Acid is a versatile Click Chemistry intermediate that serves as a key component in the development of antibody-drug conjugate (ADC) linkers. Its chemical structure facilitates efficient conjugation processes, enabling precise attachment of cytotoxic agents to antibodies. This reagent is essential for advancing research in targeted cancer therapeutics and improving drug delivery systems.

Aminooxy-PEG2-BCN is a cleavable linker designed for use in antibody-drug conjugate (ADC) synthesis. This reagent features a BCN (cyclooctyne) moiety that facilitates strain-promoted alkyne-azide cycloaddition (SPAAC) with azide-containing molecules. Its unique structure enables efficient conjugation in the development of targeted therapeutics, enhancing both delivery and efficacy of payloads in cancer research and other biomedical applications.

Mal-bis-PEG3-DBCO is a cleavable linker designed for antibody-drug conjugate (ADC) synthesis, functioning through the efficient coupling of DBCO and azide moieties. This reagent incorporates a 3-unit polyethylene glycol (PEG) chain, enhancing solubility and biocompatibility. Its mechanism relies on strain-promoted alkyne-azide cycloaddition (SPAAC), making it ideal for precise conjugation applications in targeted drug delivery and cancer therapeutics research.

PC Alkyne-PEG4-NHS ester is a cleavable linker designed for use in the synthesis of antibody-drug conjugates (ADCs). Functioning as a PROTAC linker, this reagent features an alkyne group and participates in copper-catalyzed azide-alkyne cycloaddition (CuAAc) reactions. Its unique structure enhances the specificity and efficiency of conjugating azide-containing molecules, making it valuable for various chemical biology applications, including targeted drug delivery and proteolysis targeting chimera (PROTAC) development.

TCO-PEG4-DBCO is a versatile PROTAC linker known for its ability to facilitate the synthesis of proteolysis-targeting chimeras (PROTACs). This compound features a DBCO moiety that enables strain-promoted alkyne-azide cycloaddition (SPAAC) with azide-containing compounds, while the TCO component allows for inverse electron demand Diels-Alder (iEDDA) reactions with tetrazine derivatives. TCO-PEG4-DBCO finds applications in the development of antibody-drug conjugates (ADCs), enhancing the precision and efficacy of targeted therapeutics. Its unique chemical properties make it a valuable tool for researchers in chemical biology and drug development.

Mal-PEG2-bis-PEG3-BCN is a cleavable linker designed for use in antibody-drug conjugates (ADCs). Featuring a BCN moiety, it facilitates strain-promoted alkyne-azide cycloaddition (SPAAC) with azide-containing molecules, enhancing conjugation efficiency. This reagent is ideal for the development of targeted therapies in cancer research and other applications requiring precise drug delivery mechanisms.

TCO-SS-amine is a cleavable linker designed for the synthesis of antibody-drug conjugates (ADCs). Featuring a TCO group, this reagent facilitates the inverse electron demand Diels-Alder reaction (iEDDA) with tetrazine-containing molecules. Its selective and efficient coupling capabilities make TCO-SS-amine a valuable tool in ADC development, enabling targeted delivery of therapeutic agents in cancer research and drug discovery applications.

ICG-alkyne is a click chemistry reagent characterized by the presence of an alkyne functional group, enabling efficient conjugation through the copper-catalyzed azide-alkyne cycloaddition (CuAAC) reaction. This reagent facilitates the labeling and visualization of biomolecules, making it a valuable tool in bioconjugation and imaging applications. Its utility spans various research fields, including chemical biology, biochemistry, and nanotechnology, where precise molecular interactions are essential for experimental outcomes.

Mal-Sulfo-DBCO is a cleavable linker designed for use in antibody-drug conjugate (ADC) synthesis. Featuring a DBCO moiety, it facilitates the efficient strain-promoted alkyne-azide cycloaddition (SPAAC) reaction with azide-containing compounds. This property makes Mal-Sulfo-DBCO valuable for precise conjugation in targeted drug delivery applications, enhancing therapeutic efficacy while minimizing off-target effects.

Hydroxy-PEG3-DBCO is a versatile click chemistry reagent featuring a DBCO moiety and a terminal hydroxyl group. This PEG-based linker enhances solubility for labeled molecules while enabling efficient reactions with various functional groups. DBCO facilitates copper-free click chemistry, making it suitable for a wide range of bioconjugation applications in chemical and biochemical research. Designed for use in laboratory research, this reagent provides a reliable tool for developing complex biological systems and materials.

DBCO-NHCO-PEG4-NHS ester is a versatile linker designed for use in the synthesis of PROTACs and antibody-drug conjugates (ADCs). This PEG/alkyl/ether-based compound features a DBCO moiety that facilitates strain-promoted alkyne-azide cycloaddition (SPAAC) with azide-containing molecules. Its cleavable nature enhances the functionality and targeting capabilities of therapeutic agents, making it essential for researchers involved in drug development and bioconjugation applications.

DBCO-PEG1-OH is an ADC linker designed for effective conjugation in antibody-drug conjugate (ADC) applications. This compound facilitates the synthesis of ADCs by providing a stable and efficient link between monoclonal antibodies and therapeutic agents. Its utility in ADC development supports research in targeted cancer therapies and drug delivery systems.

GDP-L-Fuc-PEG4-BCN is a cleavable linker designed for use in antibody-drug conjugates (ADCs). This linker facilitates the efficient conjugation of antibodies with cytotoxic drugs, enhancing targeted delivery to tumor cells. Its incorporation allows for controlled release of therapeutic agents upon internalization, making it suitable for cancer research and the development of innovative ADC therapeutics.

Alkyne-PEG2-iodide is a click chemistry reagent featuring a terminal alkyne and an alkyl iodide moiety. This compound serves as a versatile tool for biomolecular labeling and conjugation due to its ability to undergo efficient cycloaddition reactions. It is particularly useful in various applications, including bioconjugation, proteomics, and the development of novel therapeutics.

PC Biotin-PEG3-alkyne is a cleavable antibody-drug conjugate (ADC) linker featuring a three-unit polyethylene glycol (PEG) chain. This linker incorporates an alkyne group that enables click chemistry reactions, specifically copper-catalyzed azide-alkyne cycloaddition (CuAAc) with azide-containing compounds. It is designed for the synthesis of ADCs, facilitating targeted drug delivery in various biological research applications.

Boc-gly-PEG3-endo-BCN is a cleavable PEG-based linker designed for targeted protein degradation applications through PROTAC technology. Its biocompatible structure facilitates the synthesis of antibody-drug conjugates (ADCs) by serving as a versatile linker. The presence of a bicyclo[6.1.0]nonyne (BCN) group allows for efficient strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with azide-containing molecules, making it a valuable reagent for click chemistry in biological research.

DBCO-PEG3-C1-acid is an efficient ADC linker designed to facilitate strain-promoted azide-alkyne click reactions. This reagent serves as a powerful tool in the development of antibody-drug conjugates, enhancing target specificity and therapeutic efficacy. Its biocompatible PEG spacer provides solubility and flexibility, making it ideal for conjugating various cytotoxic agents for targeted cancer therapy applications.

TCO-PEG2-Sulfo-NHS ester-EDC Urea is a click chemistry reagent featuring an azide group, designed for selective labeling of primary amine-containing biomolecules. The compound incorporates a PEG linker and a sulfo-NHS ester moiety, enhancing solubility in aqueous buffers, facilitating its utility in bioconjugation applications. It enables the covalent attachment of TCO moieties to proteins, antibodies, and other macromolecules, while participating in inverse electron demand Diels-Alder (iEDDA) reactions with tetrazine-containing partners. This reagent is suitable for various research applications, including protein labeling and targeted drug delivery studies.

DBCO-PEG4-Val-Ala-PAB is a cleavable ADC linker that effectively targets Cathepsin B for linker cleavage. The incorporation of Val-Ala linkers facilitates the controlled release of therapeutic agents, enhancing the efficacy of antibody-drug conjugates (ADCs). The DBCO moiety enables efficient Click Chemistry reactions, while the PEG spacer enhances the aqueous solubility of the compound, making it suitable for various biochemical applications.

Mal-PEG4-bis-PEG3-DBCO is a cleavable linker designed for use in antibody-drug conjugates (ADCs), facilitating targeted delivery of therapeutics. This reagent features a DBCO group that enables strain-promoted alkyne-azide cycloaddition (SPAAC) with azide-containing molecules, allowing for efficient conjugation. Its PEGylated structure enhances solubility and provides stability in biological applications, making it suitable for ADC development and related research endeavors.

Methyltetrazine-amido-N-bis(PEG4-acid) is a click chemistry reagent that features an azide group, facilitating bioorthogonal reactions. It contains a methyltetrazine moiety and two carboxylic acid groups, enabling stable covalent bonding with TCO-containing compounds through inverse-electron demand Diels-Alder cycloaddition. This reaction occurs rapidly and with high selectivity, avoiding the need for copper catalysis or elevated temperatures. Additionally, the PEG linker enhances water solubility, while the terminal carboxylic acid can react with primary amines in the presence of coupling agents to form stable amide bonds, making it suitable for various research applications in chemical biology.

DBCO-PEG3 acetic-EVCit-PAB is a cleavable ADC linker that features a three-unit polyethylene glycol (PEG) chain. This compound facilitates the construction of antibody-drug conjugates (ADCs) by employing click chemistry through its dibenzocyclooctyne (DBCO) moiety, which engages in strain-promoted alkyne-azide cycloaddition (SPAAC) with azide-containing molecules. DBCO-PEG3 acetic-EVCit-PAB is integral in enhancing the specificity and efficacy of therapeutic agents in targeted cancer treatments, making it a valuable tool for bioconjugation research.

DBCO-PEG4-alkyne is a non-cleavable linker designed for antibody-drug conjugates (ADCs), featuring a 4-unit polyethylene glycol (PEG) chain. This compound serves as a versatile click chemistry reagent, incorporating an alkyne functional group that enables the efficient copper-catalyzed azide-alkyne cycloaddition (CuAAc) with azide-containing molecules. Its application in ADC synthesis facilitates the stable conjugation of therapeutic agents, enhancing the efficacy and selectivity of targeted cancer treatments.

Bromoacetamide-PEG4-DBCO is an efficient ADC linker that facilitates the synthesis of antibody-drug conjugates. This compound features a bromoacetamide moiety for selective labeling and a DBCO group for click chemistry applications. It is ideal for enhancing the therapeutic efficacy of targeted cancer treatments by enabling stable conjugation to antibodies. This linker is suitable for a variety of research applications focused on drug delivery systems and cancer therapeutics.

BCN-PEG4-HyNic is a cleavable linker designed for antibody-drug conjugate (ADC) synthesis, featuring a four-unit polyethylene glycol (PEG) spacer. Its primary mechanism involves click chemistry, specifically through the strain-promoted alkyne-azide cycloaddition (SPAAC) reaction, which facilitates the conjugation of azide-containing biomolecules. This reagent is ideal for researchers developing targeted therapeutics, enabling enhanced delivery and reduced systemic toxicity of cytotoxic drugs in cancer therapy.

beta-Glc-TEG-Alkyne is an alkyne-containing click chemistry reagent that facilitates the formation of covalent bonds through the copper-catalyzed azide-alkyne cycloaddition (CuAAC) mechanism. This compound exhibits significant utility in biochemical research for labeling biomolecules, studying cellular interactions, and developing bioconjugates. Its unique properties make it a valuable tool for applications in chemical biology and biopharmaceutical development.

Biotin-PEG(4)-SS-Alkyne is an alkyne-containing click chemistry reagent that facilitates bioconjugation via a bioorthogonal reaction. This compound features a biotin moiety, enabling the labeling and detection of biomolecules in various biochemical assays. Its primary applications include studying protein interactions, cellular imaging, and the development of targeted therapies, providing a valuable tool in biochemical research.

Diazido-methyltetrazine tri-arm is a versatile ADC linker designed for the synthesis of antibody-drug conjugates (ADCs). This compound facilitates the selective conjugation of cytotoxic agents to antibodies, enhancing therapeutic efficacy while minimizing off-target effects. Its structural features allow for efficient formation of stable linkages, making it suitable for various applications in ADC development and cancer research.

DBCO-PEG2-C2-acid is an efficient ADC linker that facilitates the synthesis of Antibody-Drug Conjugates (ADCs). This compound utilizes the DBCO (dibenzocyclooctyne) chemistry for site-specific conjugation, enhancing the stability and efficacy of the resulting ADCs. It is essential for researchers focused on developing targeted therapies in oncology and other therapeutic areas, allowing for improved drug delivery and minimized off-target effects.

TCO-GK-PEG4-NHS ester is an ADC linker that facilitates the synthesis of [18F]AlF-NOTA-Tz-TCO-GK-2Rs15d, which exhibits high affinity and immunoreactivity for the HER2 target. This compound features a TCO group that participates in inverse electron demand Diels-Alder (iEDDA) click chemistry reactions with tetrazine-containing molecules, allowing for precise bioconjugation applications in targeted therapies. It is suitable for research involving antibody-drug conjugates and the development of advanced molecular imaging techniques.

DBCO-S-S-acid is a cleavable linker designed for the construction of antibody-drug conjugates (ADCs). It features a DBCO group that facilitates strain-promoted alkyne-azide cycloaddition (SPAAC) with azide-containing molecules, allowing for selective and efficient conjugation. This reagent is essential in bioconjugation strategies aimed at enhancing targeted therapeutic delivery in cancer research and other therapeutic applications.

Me-Tetrazine-Me-Ph-amide-Lys(Boc)-Lys-N3 is an innovative ADC linker that facilitates the construction of antibody-drug conjugates (ADCs). This reagent provides a robust mechanism for site-specific conjugation, enhancing the therapeutic efficacy of ADCs. It is particularly useful in research applications focused on targeted cancer therapies and precision medicine.

BCN-exo-PEG2-maleimide is an ADC linker characterized by the presence of two PEG units and a bidentate macrocyclic ligand, BCN. This compound facilitates the formation of stable triazole linkages through click chemistry by reacting with azide-containing molecules, and operates without the need for catalysts. Its maleimide group is hydrolytically labile in aqueous environments, making it suitable for applications in drug delivery and bioconjugation studies.

BCN-HS-PEG2-bis(PNP) is a p-nitrophenyl-containing linker intermediate designed for use in antibody-drug conjugate (ADC) applications. It facilitates the conjugation of cytotoxins with peptide linkers, thereby enabling the formation of stable Drug-Linker Conjugates. BCN-HS-PEG2-bis(PNP) has demonstrated efficacy in coupling with vc-PABC-MMAE, making it a valuable reagent in ADC development for targeted cancer therapies.

DBCO-NHCO-PEG4-acid is a PEG-based linker designed for application in antibody-drug conjugates (ADCs) and PROTAC synthesis. This linker features a DBCO group that participates in strain-promoted alkyne-azide cycloaddition (SPAAC), facilitating selective conjugation with azide-containing molecules. Its chemical properties make it ideal for developing targeted therapeutics that can modulate protein levels in biological research, enhancing experimental outcomes in drug discovery and development.